Cargando…

Peripheral arterial disease in polymyalgia rheumatica

Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, Frances A, Dasgupta, Bhaskar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714105/
https://www.ncbi.nlm.nih.gov/pubmed/19519936
http://dx.doi.org/10.1186/ar2685
_version_ 1782169636904632320
author Borg, Frances A
Dasgupta, Bhaskar
author_facet Borg, Frances A
Dasgupta, Bhaskar
author_sort Borg, Frances A
collection PubMed
description Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors.
format Text
id pubmed-2714105
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27141052009-07-22 Peripheral arterial disease in polymyalgia rheumatica Borg, Frances A Dasgupta, Bhaskar Arthritis Res Ther Editorial Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors. BioMed Central 2009 2009-05-20 /pmc/articles/PMC2714105/ /pubmed/19519936 http://dx.doi.org/10.1186/ar2685 Text en Copyright © 2009 BioMed Central Ltd
spellingShingle Editorial
Borg, Frances A
Dasgupta, Bhaskar
Peripheral arterial disease in polymyalgia rheumatica
title Peripheral arterial disease in polymyalgia rheumatica
title_full Peripheral arterial disease in polymyalgia rheumatica
title_fullStr Peripheral arterial disease in polymyalgia rheumatica
title_full_unstemmed Peripheral arterial disease in polymyalgia rheumatica
title_short Peripheral arterial disease in polymyalgia rheumatica
title_sort peripheral arterial disease in polymyalgia rheumatica
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714105/
https://www.ncbi.nlm.nih.gov/pubmed/19519936
http://dx.doi.org/10.1186/ar2685
work_keys_str_mv AT borgfrancesa peripheralarterialdiseaseinpolymyalgiarheumatica
AT dasguptabhaskar peripheralarterialdiseaseinpolymyalgiarheumatica